nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia
|
Fujimoto, Daichi |
|
2017 |
111 |
C |
p. 1-5 5 p. |
artikel |
2 |
Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery
|
Gagliasso, Matteo |
|
2017 |
111 |
C |
p. 124-130 7 p. |
artikel |
3 |
Assessment of interfering factors and clinical risk associated with discontinuation of pemetrexed maintenance therapy in advanced non-squamous non-small cell lung cancer
|
Shen, Lan |
|
2017 |
111 |
C |
p. 43-50 8 p. |
artikel |
4 |
Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions
|
Sculier, Claudine |
|
2017 |
111 |
C |
p. 164-175 12 p. |
artikel |
5 |
Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles
|
Ruelle, Lucien |
|
2017 |
111 |
C |
p. 150-163 14 p. |
artikel |
6 |
Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results
|
Hicks, J. Kevin |
|
2017 |
111 |
C |
p. 135-138 4 p. |
artikel |
7 |
Chest ultrasonography in health surveillance of asbestos related pleural disease
|
Scarlata, Simone |
|
2017 |
111 |
C |
p. 139-142 4 p. |
artikel |
8 |
Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer
|
Miura, Kentaro |
|
2017 |
111 |
C |
p. 88-95 8 p. |
artikel |
9 |
Contents
|
|
|
2017 |
111 |
C |
p. v-vii nvt p. |
artikel |
10 |
Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas® EGFR mutation test
|
Satouchi, Miyako |
|
2017 |
111 |
C |
p. 190-194 5 p. |
artikel |
11 |
Editorial Board
|
|
|
2017 |
111 |
C |
p. iii- 1 p. |
artikel |
12 |
Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib
|
Oztan, A. |
|
2017 |
111 |
C |
p. 84-87 4 p. |
artikel |
13 |
Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients
|
Ou, Sai-Hong Ignatius |
|
2017 |
111 |
C |
p. 61-64 4 p. |
artikel |
14 |
Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours
|
Kajiura, Koichiro |
|
2017 |
111 |
C |
p. 116-123 8 p. |
artikel |
15 |
Full circle: Extranodal marginal zone B-cell lymphoma of the trachea
|
Sampat, Devi |
|
2017 |
111 |
C |
p. 12-14 3 p. |
artikel |
16 |
Ipsilateral pleural recurrence after diagnostic transthoracic needle biopsy in pathological stage I lung cancer patients who underwent curative resection
|
Moon, Seong Mi |
|
2017 |
111 |
C |
p. 69-74 6 p. |
artikel |
17 |
Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer
|
Tokaca, Nadza |
|
2017 |
111 |
C |
p. 65-68 4 p. |
artikel |
18 |
Lung cancer in renal transplant recipients: A case-control study
|
Rousseau-Gazaniol, Claire |
|
2017 |
111 |
C |
p. 96-100 5 p. |
artikel |
19 |
Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer
|
Califano, Raffaele |
|
2017 |
111 |
C |
p. 51-58 8 p. |
artikel |
20 |
Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study
|
Gobbini, Elisa |
|
2017 |
111 |
C |
p. 30-37 8 p. |
artikel |
21 |
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
|
Diem, Stefan |
|
2017 |
111 |
C |
p. 176-181 6 p. |
artikel |
22 |
Pathological complete response in malignant pleural mesothelioma patients following induction chemotherapy: Predictive factors and outcomes
|
Lau, Brandon |
|
2017 |
111 |
C |
p. 75-78 4 p. |
artikel |
23 |
Peritoneal recurrence of thymoma treated by surgery and hyperthermic intraperitoneal chemotherapy
|
Mazza, Camille |
|
2017 |
111 |
C |
p. 59-60 2 p. |
artikel |
24 |
Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?
|
Capelan, Marta |
|
2017 |
111 |
C |
p. 6-11 6 p. |
artikel |
25 |
Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC
|
Gerber, David E. |
|
2017 |
111 |
C |
p. 108-115 8 p. |
artikel |
26 |
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project
|
Bubendorf, Lukas |
|
2017 |
111 |
C |
p. 143-149 7 p. |
artikel |
27 |
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
|
Labbé, Catherine |
|
2017 |
111 |
C |
p. 23-29 7 p. |
artikel |
28 |
Programmed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancer
|
Hata, Akito |
|
2017 |
111 |
C |
p. 182-189 8 p. |
artikel |
29 |
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901
|
Morikawa, Naoto |
|
2017 |
111 |
C |
p. 38-42 5 p. |
artikel |
30 |
Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening
|
Taghizadeh, Niloofar |
|
2017 |
111 |
C |
p. 101-107 7 p. |
artikel |
31 |
TR3 is involved in hypoxia-induced apoptosis resistance in lung cancer cells downstream of HIF-1α
|
Wohlkoenig, Christoph |
|
2017 |
111 |
C |
p. 15-22 8 p. |
artikel |
32 |
Uniform and blinded cause of death verification of the NELSON lung cancer screening participants
|
Yousaf-Khan, A.U. |
|
2017 |
111 |
C |
p. 131-134 4 p. |
artikel |
33 |
Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer
|
Lim, Sun Min |
|
2017 |
111 |
C |
p. 79-83 5 p. |
artikel |